Gatmaitan B G, Legaspi R C, Levy H B, Lerner A M
Antimicrob Agents Chemother. 1980 Jan;17(1):49-54. doi: 10.1128/AAC.17.1.49.
The purposes of this study were to determine whether the febrile and hypotensive reactions to the administration of polyriboinosinic-polyribocytidylic acid [poly (I)-poly (C)] complexed with poly-L-lysine and carboxymethylcellulose (poly ICLC) (9S) encountered in humans could be duplicated in rabbits, and when such duplication was demonstrated, to ascertain whether these untoward reactions could be avoided by (i) administration of hydrocortisone (HC), (ii) alteration of the route of delivery, or (iii) administration of poly ICLC (4S) an interferon inducer of lower molecular weight. Responses to intravenous poly ICLC (9S) in rabbits reproduced adverse reactions in humans, namely fever and hypotension, and were accompanied by high titers of serum interferon. Continuing investigations showed that (i) intravenous pretreatment of rabbits with HC ameliorated hypotensive responses but markedly diminished interferon induction. When HC was given after poly ICLC (9S), both interferon and hypotension induction were likewise depressed. (ii) Intramuscular or subcutaneous poly ICLC (9S) produced neither high titers of serum interferon nor toxic effects. (iii) Poly ICLC (4S) induced high titers of serum interferon and fever, but no hypotension. Poly ICLC (4S) warrants further study.
本研究的目的是确定人类中出现的与聚-L-赖氨酸和羧甲基纤维素复合的聚肌苷酸-聚胞苷酸[聚(I)-聚(C)](9S)给药相关的发热和低血压反应是否能在兔中重现,当证明这种重现时,确定是否可通过以下方式避免这些不良反应:(i)给予氢化可的松(HC),(ii)改变给药途径,或(iii)给予分子量较低的干扰素诱导剂聚(I)-聚(C)(4S)。兔对静脉注射聚(I)-聚(C)(9S)的反应重现了人类的不良反应,即发热和低血压,并伴有高滴度的血清干扰素。持续研究表明:(i)兔静脉注射HC预处理可改善低血压反应,但显著降低干扰素诱导。当在聚(I)-聚(C)(9S)后给予HC时,干扰素和低血压诱导同样受到抑制。(ii)肌肉注射或皮下注射聚(I)-聚(C)(9S)既不产生高滴度的血清干扰素,也不产生毒性作用。(iii)聚(I)-聚(C)(4S)诱导高滴度的血清干扰素和发热,但无低血压。聚(I)-聚(C)(4S)值得进一步研究。